tiprankstipranks

Oh Chad Insider Profile

4 Followers
Oh Chad, CMO at AEON Biopharma, holds 292.55K shares in AEON Biopharma (Ticker: AEON).
tipranks
Oh Chad

Oh Chad
AEON Biopharma (AEON)
CMO

Not Ranked
Oh Chad has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$164K
100.00%
A breakdown of Oh Chad's holdings

Insider Roles

AEON Biopharma
(AEON)
CMO
Roles that Oh Chad holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Oh Chad

Oh Chad's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
AEON Biopharma
Sep 04, 2024
CMO
Uninformative Buy
$163.53K
Oh Chad has not reported any informative transactions for AEON, therefore, performance cannot be measured.
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Sep 04, 2024
Uninformative Buy
$0.00
-
$0.00
List of latest transactions for each holding click on a transaction to see Oh Chad's performance on stock

Oh Chad insider profile FAQ

What is the percentage of profitable transactions made by Oh Chad?
The percentage of profitable transactions made by Oh Chad is ―.
    What is the average return per transaction made by Oh Chad?
    The average return per transaction made by Oh Chad is ―.
      What stocks does Oh Chad hold?
      Oh Chad holds: AEON stocks.
        What was Oh Chad’s latest transaction?
        Oh Chad latest transaction was an Uninformative Buy of ―.
          What was Oh Chad's most profitable transaction?
          Oh Chad’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Oh Chad's role in AEON Biopharma?
            Oh Chad's role in AEON Biopharma is CMO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.